Role of NF-κB activation in intestinal immune homeostasis

International Journal of Medical Microbiology

Volumn 300, Issue 1, 2010, Pages 49-56

  Wullaert, Andy ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Commensals; Inflammatory bowel disease; Intestine; NF B; NOD like receptors; Toll like receptors

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR;

CYTOKINE PRODUCTION; ENTERITIS; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INTESTINE FLORA; NONHUMAN; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BACTERIUM; IMMUNITY; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MOUSE; REVIEW;

ANIMALS; BACTERIA; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; IMMUNITY; INTESTINES; MICE; NF-KAPPA B;

EID: 71649089949     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2009.08.007     Document Type: Short Survey

References (68)

1. Abbott D.W., Yang Y., Hutti J.E., Madhavarapu S., Kelliher M.A., and Cantley L.C. Coordinate regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol. Cell. Biol. 27 (2007) 6012-6025
2. Araki A., Kanai T., Ishikura T., Makita S., Uraushihara K., Iiyama R., Totsuka T., Takeda K., Akira S., and Watanabe M. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40 (2005) 16-23
3. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., and Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25 (2000) 187-191
4. Brown S.L., Riehl T.E., Walker M.R., Geske M.J., Doherty J.M., Stenson W.F., and Stappenbeck T.S. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J. Clin. Invest. 117 (2007) 258-269
5. Cario E., and Podolsky D.K. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68 (2000) 7010-7017
6. Cario E., Gerken G., and Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132 (2007) 1359-1374
7. Courtois G. Tumor suppressor CYLD: negative regulation of NF-kappaB signaling and more. Cell. Mol. Life Sci. 65 (2008) 1123-1132
8. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309 (2005) 1854-1857
9. Dave S.H., Tilstra J.S., Matsuoka K., Li F., Karrasch T., Uno J.K., Sepulveda A.R., Jobin C., Baldwin A.S., Robbins P.D., and Plevy S.E. Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J. Immunol. 179 (2007) 7852-7859
10. Eckmann L., Nebelsiek T., Fingerle A.A., Dann S.M., Mages J., Lang R., Robine S., Kagnoff M.F., Schmid R.M., Karin M., Arkan M.C., and Greten F.R. Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc. Natl. Acad. Sci. USA 105 (2008) 15058-15063
11. Ellis R.D., Goodlad J.R., Limb G.A., Powell J.J., Thompson R.P., and Punchard N.A. Activation of nuclear factor kappa B in Crohn's disease. Inflamm. Res. 47 (1998) 440-445
12. Erdman S., Fox J.G., Dangler C.A., Feldman D., and Horwitz B.H. Typhlocolitis in NF-kappa B-deficient mice. J. Immunol. 166 (2001) 1443-1447
13. Fox J.G., Rogers A.B., Whary M.T., Ge Z., Taylor N.S., Xu S., Horwitz B.H., and Erdman S.E. Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect. Immun. 72 (2004) 1116-1125
14. Franchi L., Park J.H., Shaw M.H., Marina-Garcia N., Chen G., Kim Y.G., and Nunez G. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell. Microbiol. 10 (2008) 1-8
15. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., Quertinmont E., Abramowicz M., Van Gossum A., Deviere J., and Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53 (2004) 987-992
16. Fukata M., Michelsen K.S., Eri R., Thomas L.S., Hu B., Lukasek K., Nast C.C., Lechago J., Xu R., Naiki Y., Soliman A., Arditi M., and Abreu M.T. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G1055-1065
17. Fukata M., Chen A., Klepper A., Krishnareddy S., Vamadevan A.S., Thomas L.S., Xu R., Inoue H., Arditi M., Dannenberg A.J., and Abreu M.T. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131 (2006) 862-877
18. Garlanda C., Riva F., Polentarutti N., Buracchi C., Sironi M., De Bortoli M., Muzio M., Bergottini R., Scanziani E., Vecchi A., Hirsch E., and Mantovani A. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc. Natl. Acad. Sci. USA 101 (2004) 3522-3526
19. Garlanda C., Riva F., Veliz T., Polentarutti N., Pasqualini F., Radaelli E., Sironi M., Nebuloni M., Zorini E.O., Scanziani E., and Mantovani A. Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res. 67 (2007) 6017-6021
20. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., and Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167 (2001) 1882-1885
21. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., Kagnoff M.F., and Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
22. Hayden M.S., West A.P., and Ghosh S. NF-kappaB and the immune response. Oncogene 25 (2006) 6758-6780
23. Hayden M.S., and Ghosh S. Shared principles in NF-kappaB signaling. Cell 132 (2008) 344-362
24. Heimesaat M.M., Fischer A., Siegmund B., Kupz A., Niebergall J., Fuchs D., Jahn H.K., Freudenberg M., Loddenkemper C., Batra A., Lehr H.A., Liesenfeld O., Blaut M., Gobel U.B., Schumann R.R., and Bereswill S. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS ONE 2 (2007) e662
25. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
26. Jobin C., Bradham C.A., Russo M.P., Juma B., Narula A.S., Brenner D.A., and Sartor R.B. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J. Immunol. 163 (1999) 3474-3483
27. Kajino-Sakamoto R., Inagaki M., Lippert E., Akira S., Robine S., Matsumoto K., Jobin C., and Ninomiya-Tsuji J. Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J. Immunol. 181 (2008) 1143-1152
28. Karrasch T., Kim J.S., Muhlbauer M., Magness S.T., and Jobin C. Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J. Immunol. 178 (2007) 6522-6532
29. Kawai T., and Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13 (2007) 460-469
30. Kim Y.G., Park J.H., Daignault S., Fukase K., and Nunez G. Cross-tolerization between Nod1 and Nod2 signaling results in reduced refractoriness to bacterial infection in Nod2-deficient macrophages. J. Immunol. 181 (2008) 4340-4346
31. Kim Y.G., Park J.H., Shaw M.H., Franchi L., Inohara N., and Nunez G. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28 (2008) 246-257
32. Kumagai Y., Takeuchi O., and Akira S. Pathogen recognition by innate receptors. J. Infect. Chemother. 14 (2008) 86-92
33. Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., Lee H.K., Shen C., Cojocaru G., Shenouda S., Kagnoff M., Eckmann L., Ben-Neriah Y., and Raz E. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 8 (2006) 1327-1336
34. Li J., Moran T., Swanson E., Julian C., Harris J., Bonen D.K., Hedl M., Nicolae D.L., Abraham C., and Cho J.H. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum. Mol. Genet. 13 (2004) 1715-1725
35. Maeda S., Hsu L.C., Liu H., Bankston L.A., Iimura M., Kagnoff M.F., Eckmann L., and Karin M. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307 (2005) 734-738
36. Martinon F., Gaide O., Petrilli V., Mayor A., and Tschopp J. NALP inflammasomes: a central role in innate immunity. Semin. Immunopathol. 29 (2007) 213-229
37. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M.F., and Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446 (2007) 557-561
38. Netea M.G., Ferwerda G., de Jong D.J., Girardin S.E., Kullberg B.J., and van der Meer J.W. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype. Neth. J. Med. 63 (2005) 305-308
39. Netea M.G., Ferwerda G., de Jong D.J., Jansen T., Jacobs L., Kramer M., Naber T.H., Drenth J.P., Girardin S.E., Kullberg B.J., Adema G.J., and Van der Meer J.W. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J. Immunol. 174 (2005) 6518-6523
40. Neurath M.F., Pettersson S., Meyer zum Buschenfelde K.H., and Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2 (1996) 998-1004
41. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
42. Ohkawara T., Takeda H., Nishihira J., Miyashita K., Nihiwaki M., Ishiguro Y., Takeda K., Akira S., Iwanaga T., Sugiyama T., and Asaka M. Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice. Clin. Exp. Immunol. 141 (2005) 412-421
43. Otte J.M., Cario E., and Podolsky D.K. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126 (2004) 1054-1070
44. Pasparakis M., Luedde T., and Schmidt-Supprian M. Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice. Cell Death Differ. 13 (2006) 861-872
45. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., Rutgeerts P., and Vermeire S. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 12 (2006) 1-8
46. Pull S.L., Doherty J.M., Mills J.C., Gordon J.I., and Stappenbeck T.S. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA 102 (2005) 99-104
47. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., and Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118 (2004) 229-241
48. Rakoff-Nahoum S., Hao L., and Medzhitov R. Role of Toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25 (2006) 319-329
49. Reiley W.W., Jin W., Lee A.J., Wright A., Wu X., Tewalt E.F., Leonard T.O., Norbury C.C., Fitzpatrick L., Zhang M., and Sun S.C. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J. Exp. Med. 204 (2007) 1475-1485
50. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P.A., Scholmerich J., and Gross V. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115 (1998) 357-369
51. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008) 577-594
52. Sartor R.B., and Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr. Gastroenterol. Rep. 9 (2007) 497-507
53. Schreiber S., Nikolaus S., and Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42 (1998) 477-484
54. Shibata W., Maeda S., Hikiba Y., Yanai A., Ohmae T., Sakamoto K., Nakagawa H., Ogura K., and Omata M. Cutting edge: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J. Immunol. 179 (2007) 2681-2685
55. Steinbrecher K.A., Harmel-Laws E., Sitcheran R., and Baldwin A.S. Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. J. Immunol. 180 (2008) 2588-2599
56. Sugimoto K., Hanai H., Tozawa K., Aoshi T., Uchijima M., Nagata T., and Koide Y. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123 (2002) 1912-1922
57. Takagi H., Kanai T., Okazawa A., Kishi Y., Sato T., Takaishi H., Inoue N., Ogata H., Iwao Y., Hoshino K., Takeda K., Akira S., Watanabe M., Ishii H., and Hibi T. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand. J. Gastroenterol. 38 (2003) 837-844
58. Tomczak M.F., Erdman S.E., Poutahidis T., Rogers A.B., Holcombe H., Plank B., Fox J.G., and Horwitz B.H. NF-kappa B is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J. Immunol. 171 (2003) 1484-1492
59. van Heel D.A., Ghosh S., Butler M., Hunt K.A., Lundberg A.M., Ahmad T., McGovern D.P., Onnie C., Negoro K., Goldthorpe S., Foxwell B.M., Mathew C.G., Forbes A., Jewell D.P., and Playford R.J. Muramyl dipeptide and Toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365 (2005) 1794-1796
60. Wang Y., Rickman B.H., Poutahidis T., Schlieper K., Jackson E.A., Erdman S.E., Fox J.G., and Horwitz B.H. c-Rel is essential for the development of innate and T cell-induced colitis. J. Immunol. 180 (2008) 8118-8125
61. Watanabe T., Kitani A., Murray P.J., and Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5 (2004) 800-808
62. Watanabe T., Kitani A., Murray P.J., Wakatsuki Y., Fuss I.J., and Strober W. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 25 (2006) 473-485
63. Watanabe T., Asano N., Murray P.J., Ozato K., Tailor P., Fuss I.J., Kitani A., and Strober W. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118 (2008) 545-559
64. Xiao H., Gulen M.F., Qin J., Yao J., Bulek K., Kish D., Altuntas C.Z., Wald D., Ma C., Zhou H., Tuohy V.K., Fairchild R.L., de la Motte C., Cua D., Vallance B.A., and Li X. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26 (2007) 461-475
65. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., and Kelliher M.A. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 282 (2007) 36223-36229
66. Yang Z., Fuss I.J., Watanabe T., Asano N., Davey M.P., Rosenbaum J.T., Strober W., and Kitani A. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. Gastroenterology 133 (2007) 1510-1521
67. Zaph C., Troy A.E., Taylor B.C., Berman-Booty L.D., Guild K.J., Du Y., Yost E.A., Gruber A.D., May M.J., Greten F.R., Eckmann L., Karin M., and Artis D. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446 (2007) 552-556
68. Zhang J., Stirling B., Temmerman S.T., Ma C.A., Fuss I.J., Derry J.M., and Jain A. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J. Clin. Invest. 116 (2006) 3042-3049